Neurodegenerative Diseases

Papers
(The median citation count of Neurodegenerative Diseases is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline18
Inflammatory Cytokine Levels in Patients with Sporadic Amyotrophic Lateral Sclerosis14
Association between Gut Microbiota with Mild Cognitive Impairment and Alzheimer’s Disease in a Thai Population13
Review of Available Data for the Efficacy and Effectiveness of Nabiximols Oromucosal Spray (Sativex®) in Multiple Sclerosis Patients with Moderate to Severe Spasticity11
Prevalence of Gastrointestinal Symptoms, Severity of Dysphagia, and Their Correlation with Severity of Amyotrophic Lateral Sclerosis in a Mexican Cohort9
Cerebrospinal Fluid Levels of 5-Hydroxyindoleacetic Acid in Parkinson’s Disease and Atypical Parkinsonian Syndromes9
The Immunomodulatory Potential Role of Mesenchymal Stem Cells in Diseases of the Central Nervous System6
Synaptic Neurofilaments and GluN1-Neurofilament Light Chain Interaction in Experimental Models of α-Synucleinopathies5
Homoharringtonine Inhibits Alzheimer’s Disease Progression by Reducing Neuroinflammation via STAT3 Signaling in APP/PS1 Mice5
Neuroprotective and Therapeutic Effects of Tocovid and Twendee-X on Aβ Oligomer-Induced Damage in the SH-SY5Y Cell Line4
Heart Rate Variability during Wake and Sleep in Huntington’s Disease Patients: An Observational, Cross-Sectional, Cohort Study4
Increased Intake of Fast-Acting Carbohydrates in Patients with Parkinson’s Disease2
Plasma Cystatin C Correlates with Plasma NfL Levels and Predicts Disease Progression in Parkinson’s Disease2
Natural Age-Related Slow-Wave Sleep Alterations Onset Prematurely in the Tg2576 Mouse Model of Alzheimer’s Disease2
Sexuality and Neurodegenerative Disease: An Unmet Challenge for Patients, Caregivers, and Treatment2
Diagnostic Accuracy of Noun- and Verb-Naming Tasks in Detecting Cognitive Impairment in Parkinson’s Disease2
Early Autonomic Symptoms Predict Functional Decline in Parkinson’s Disease Independent of Dopaminergic Therapy2
Cancer in Parkinson’s Disease: An Approximation to the Main Risk Factors1
Heart Rate Variability in Huntington Disease: A Long-Term Longitudinal Study1
Clinical Manifestations Associated with the Domain-Containing Protein 2 Gene Mutation in an Iranian Family with Spastic Paraplegia 541
Association between Excessive Daytime Sleepiness and the Cholinergic Ascending Reticular System in Parkinson’s Disease1
Characteristics of Late-Onset Amyotrophic Lateral Sclerosis in a Chinese Cohort1
4-Phthalimidobenzenesulfonamide Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: DFTs, 3D-QSAR, ADMET, and Molecular Dynamics Simulation1
Tit for Tat: Costly Punishment in Manifest Huntington’s Disease1
Lithium: An Old Drug for New Therapeutic Strategy for Alzheimer’s Disease and Related Dementia1
Hippocampal Functional Connectivity in Parkinson’s Disease1
Age of Onset and Length of Survival of Queensland Patients with Amyotrophic Lateral Sclerosis: Details of Subjects with Early Onset and Subjects with Long Survival1
Ecological Validity of the Montreal Cognitive Assessment in Non-Demented Parkinson’s Disease Patients1
CSF Aβ40 and P-Tau181 Might Differentiate Atypical from Typical AD Phenotypes: Preliminary Evidence1
Frontostriatal Circuits Alterations Associated with Cognitive Flexibility Deterioration in Huntington’s Disease1
The Two-Way Route between Delirium Disorder and Dementia: Insights from COVID-191
0.016700029373169